<SEC-DOCUMENT>0000899243-23-009799-index.html : 20230328
<SEC-HEADER>0000899243-23-009799.hdr.sgml : 20230328
<ACCEPTANCE-DATETIME>20230328170013
ACCESSION NUMBER:		0000899243-23-009799
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230324
FILED AS OF DATE:		20230328
DATE AS OF CHANGE:		20230328

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Reardon Andrew
		CENTRAL INDEX KEY:			0001950232

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		23770369

	MAIL ADDRESS:	
		STREET 1:		C/O LIGAND PHARMACEUTICALS INCORPORATED
		STREET 2:		3911 SORRENTO VALLEY BLVD, SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>